Key facts
- This page summarizes Risa Cretella's Form 4 filing for Sovos Brands, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 28 Mar 2023, 16:03.
Risa Cretella - 27 Mar 2023 Form 4 Insider Report for Sovos Brands, Inc.
- Reporting relationship
- CHIEF SALES OFFICER
- Issuer ticker
- N/A
- Reported as of
- 27 Mar 2023
- Net transaction value
- -$237,930
- SEC form
- 4
- Accepted by SEC
- 28 Mar 2023, 16:03:30 UTC
- Prior SEC filing
- 14 Feb 2023
- Next SEC filing
- 05 Apr 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Isobel A. Jones, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Risa Cretella filed Form 4 for Sovos Brands, Inc. on 28 Mar 2023.
Change
- Previous filing in this sequence was filed on 14 Feb 2023.
- Current net transaction value: -$237,930.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SOVO
transaction
Common Stock
Sale
- Transaction value
- $237,930
- Shares
- -14,420
- Change %
- -4.7%
- Price
- $16.50
- Shares after
- 294,927
- Date
- 27 Mar 2023
- Ownership
- Direct
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
This transaction was effected pursuant to a written plan that was adopted by the Reporting Person prior to the SEC's adoption of amendments to Rule 10b5-1 of the Exchange Act in December 2022 and was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) as in effect at the time of adoption. The plan was structured to include several sale periods and was established as part of the Reporting Person's long-term strategy for asset diversification and financial, retirement, estate and tax planning activities over a period of time.
Footnote F2
Represents actual sale price.
Footnote F3
Includes 47,055 restricted shares of common stock of the Issuer subject to time-based vesting and the Reporting Person's continued service with the Issuer (a portion of which will vest on December 30,2023, September 23, 2024 or September 23, 2025, if original performance goals are not earlier achieved), 67,508 restricted shares of common stock of the Issuer subject to performance-based vesting and the Reporting Person's continued service with the Issuer, and 90,751 restricted stock units subject to time-based vesting, subject to the terms of the applicable award agreement.